Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

General Notices

NIH Announces the Open Period of FY 2021 Helium-3 Requests for Medical Research
(NOT-HL-20-810)
National Heart, Lung, and Blood Institute

Notice of Changes to Funding Opportunities

Notice of Correction to RFA-OD-20-013 "Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)" for Award Information about Clinical Trials
(NOT-OD-20-149)
National Institutes of Health

Notice of Change to Funding Announcement (NOT-OD-20-048) by the Office of Research on Women's Health (ORWH), " Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)"
(NOT-OD-20-156)
Office of Research on Women's Health

Notice to Clarify and Correct Eligibility in Notices of Special Interest under the Rapid Acceleration of Diagnostics Underserved Populations (RADx-UP) Program
(NOT-OD-20-157)
National Institutes of Health
Office of Research on Women's Health

Notices of Special Interest

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19).
(NOT-OD-20-159)
National Institutes of Health
National Library of Medicine

Funding Opportunities

Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed)
(RFA-OD-20-017)
National Institutes of Health
National Center for Advancing Translational Sciences
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute on Minority Health and Health Disparities
National Library of Medicine
Application Receipt Date(s): September 18, 2020 N?o late applications will be accepted for this Funding Opportunity Announcement.

Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)
(RFA-OD-20-018)
National Institutes of Health
National Center for Advancing Translational Sciences
National Cancer Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): September 18, 2020 No late applications will be accepted for this Funding Opportunity Announcement.

Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed)
(RFA-OD-20-019)
National Institutes of Health
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
National Library of Medicine
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): September 30, 2020 No late applications will be accepted for this Funding Opportunity Announcement.

Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed)
(RFA-OD-20-020)
National Institutes of Health
National Center for Advancing Translational Sciences
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute on Minority Health and Health Disparities
National Library of Medicine
Application Receipt Date(s): September 18, 2020

Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)
(RFA-OD-20-021)
National Institutes of Health
National Center for Advancing Translational Sciences
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute on Minority Health and Health Disparities
National Library of Medicine
Application Receipt Date(s): September 18, 2020

Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)
(RFA-OD-20-023)
National Institutes of Health
John E. Fogarty International Center
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): September 30, 2020. No late applications will be accepted for this Funding Opportunity Announcement.